Orion recommits to profitability target, R&D amid share price slump

Auckland-based health IT firm Orion Health is still aiming to be profitable in the 2018 financial year and has recommitted to its R&D program despite forecasting lower than expected operating revenue for the current year, which saw its share price slump by 14.5 per cent.

Orion Health, which listed on both the New Zealand and Australian stock exchanges in late 2014 at an initial price of $NZ5.70, is trading at about $1.42 today. It had been trading steadily last year at about $3.50.

Posted in New Zealand eHealth

Tags: Orion Health

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.